Candel Therapeutics Inc (CADL)

SG&A Expenses

$22.86M

TTM · Period ending: · USD

CADL logo

CADL SG&A Expenses

Latest reported$22.86M
CADL SG&A Expenses ($2.56M → $22.86M)
High-resolution chart · PNG

CADL sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Candel Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
17,770,000
14,057,000
13,885,000
14,060,000
10,673,000
5,181,000
2,555,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.